(Q67915374)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1850114%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

title

Immunological adjuvants: desirable properties and side-effects (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1850114%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

Immunological adjuvants: Desirable properties and side-effects (English)

1 reference

https://api.crossref.org/works/10.1016/0161-5890(91)90074-T

9 December 2022

1 reference

1 reference

https://api.crossref.org/works/10.1016/0161-5890(91)90074-T

9 December 2022

author name string

A. C. Allison

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1850114

9 December 2022

N. E. Byars

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1850114

9 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1850114

9 December 2022

publication date

1 March 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1850114%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

19 September 2019

https://api.elsevier.com/content/article/PII:016158909190074T?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0161-5890(91)90074-T

https://api.elsevier.com/content/article/PII:016158909190074T?httpAccept=text/plain

9 December 2022

1 reference

https://api.crossref.org/works/10.1016/0161-5890(91)90074-T

9 December 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1850114%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1850114%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1850114%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

page(s)

279-284

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1850114%20AND%20SRC:MED&resulttype=core&format=json

An adjuvant formulation that selectively elicits the formation of antibodies of protective isotypes and of cell-mediated immunity

19 September 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0161-5890(91)90074-T

Protection from genital herpes simplex virus type 2 infection by vaccination with cloned type 1 glycoprotein D.

9 December 2022

3

1 reference

https://api.crossref.org/works/10.1016/0161-5890(91)90074-T

Adjuvant formulation for use in vaccines to elicit both cell-mediated and humoral immunity

9 December 2022

5

1 reference

https://api.crossref.org/works/10.1016/0161-5890(91)90074-T

Enhancement of antibody responses to influenza B virus haemagglutinin by use of a new adjuvant formulation

9 December 2022

6

1 reference

https://api.crossref.org/works/10.1016/0161-5890(91)90074-T

Development of a new therapeutic approach to B cell malignancy. The induction of immunity by the host against cell surface receptor on the tumor

9 December 2022

8

1 reference

https://api.crossref.org/works/10.1016/0161-5890(91)90074-T

Biological activity of a new synthetic muramyl peptide adjuvant devoid of pyrogenicity

9 December 2022

9

1 reference

https://api.crossref.org/works/10.1016/0161-5890(91)90074-T

Correlation between in vivo anti-Pseudomonas and anti-Candida activities and clearance of carbon by the reticuloendothelial system for various muramyl dipeptide analogs, using normal and immunosuppressed mice.

9 December 2022

13

1 reference

https://api.crossref.org/works/10.1016/0161-5890(91)90074-T

HLA-B27, Klebsiella and Ankylosing Spondylitis: Biological and Chemical Studies

9 December 2022

14

1 reference

https://api.crossref.org/works/10.1016/0161-5890(91)90074-T

The adjuvant activity of nonionic block polymer surfactants. I. The role of hydrophile-lipophile balance

9 December 2022

16

1 reference

https://api.crossref.org/works/10.1016/0161-5890(91)90074-T

Phase I clinical trial of a World Health Organisation birth control vaccine.

9 December 2022

17

1 reference

https://api.crossref.org/works/10.1016/0161-5890(91)90074-T

Influence of adjuvants on the quantity, affinity, isotype and epitope specificity of murine antibodies

9 December 2022

19

1 reference

https://api.crossref.org/works/10.1016/0161-5890(91)90074-T

Prevention of simian acquired immune deficiency syndrome with a formalin-inactivated type D retrovirus vaccine.

9 December 2022

20

1 reference

https://api.crossref.org/works/10.1016/0161-5890(91)90074-T

Validation of a first-generation Epstein-Barr virus vaccine preparation suitable for human use.

9 December 2022

22

1 reference

https://api.crossref.org/works/10.1016/0161-5890(91)90074-T

Immune interferon release when a cloned cytotoxic T-cell line meets its correct influenza-infected target cell

9 December 2022

23

1 reference

https://api.crossref.org/works/10.1016/0161-5890(91)90074-T

A formalin-inactivated whole SIV vaccine confers protection in macaques

9 December 2022

24

1 reference

https://api.crossref.org/works/10.1016/0161-5890(91)90074-T

Muramyl dipeptide-induced adjuvant arthritis

9 December 2022

25

1 reference

https://api.crossref.org/works/10.1016/0161-5890(91)90074-T

Necrotic inflammatory reaction induced by muramyl dipeptide in guinea pigs sensitized by tubercle bacilli

9 December 2022

26

1 reference

https://api.crossref.org/works/10.1016/0161-5890(91)90074-T

Clinical studies of monovalent inactivated whole virus and subunit A/USSR/77 (H1N1) vaccine: serological responses and clinical reactions

9 December 2022

27

1 reference

https://api.crossref.org/works/10.1016/0161-5890(91)90074-T

Reshaping human antibodies for therapy

9 December 2022

28

1 reference

https://api.crossref.org/works/10.1016/0161-5890(91)90074-T

Differential regulation of IgG1 and IgE synthesis by interleukin 4.

9 December 2022

31

1 reference

https://api.crossref.org/works/10.1016/0161-5890(91)90074-T

Granuloma formation in normal guinea pigs injected intradermally with aluminum and zirconium compounds

9 December 2022

33

1 reference

https://api.crossref.org/works/10.1016/0161-5890(91)90074-T

Structure and function of human and murine receptors for IgG.

9 December 2022

34

1 reference

https://api.crossref.org/works/10.1016/0161-5890(91)90074-T

HIV-1 reverse transcriptase is a target for cytotoxic T lymphocytes in infected individuals

9 December 2022

35

1 reference

https://api.crossref.org/works/10.1016/0161-5890(91)90074-T

Anti-peptide antibodies detect steps in a protein conformational change: low-pH activation of the influenza virus hemagglutinin

9 December 2022

38

1 reference

https://api.crossref.org/works/10.1016/0161-5890(91)90074-T

The adjuvant effect of microbial products on the immune response

9 December 2022

39

1 reference

https://api.crossref.org/works/10.1016/0161-5890(91)90074-T

9 December 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1850114%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

1 reference